Tiziana Life Sciences Ltd (TLSA)

CIK 0001723069 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024
FY-2024 —
FY-2023 —
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Balance Sheets
—
Consolidated Balance Sheets (P)
—
Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Operations and Comprehensive Loss (P)
—
Consolidated Statements of Shareholders Equity
—
Consolidated Statements of Cash Flows
—
Notes
Accounting Policies
—
Capital Risk Management
—
Contingent Liabilities
—
Critical Accounting Judgement
—
Cybersecurity Risk Management and Strategy Disclosure
—
Deferred Income
—
Employees
—
Finance Costs
—
Finance/other Income Revenue and Costs
—
Financial Commitments
—
Financial Instruments
—
General Information
—
Insider Trading Policies and Procedures
—
Investment In Related Party
—
Leases
—
Loss Per Share
—
Operating Loss
—
Other (expense)/ Income
—
Other Receivables
—
Related Party Transactions
—
Remuneration of Key Management Personnel
—
Reserves
—
Segmental Reporting
—
Share Based Payments
—
Share Capital and Share Premium
—
Subsequent Events
—
Taxation
—
Trade and Other Payables
—
Treasury Shares
—